Main > RHEUMATOLOGY > USA. A. PsA>Treat>JAK Inh. Tab.

---

USA. A. PsA>Treat>JAK Inh. Tab.'s subsections
(*) EU CE Mark Date: 2021. 01.25
(*) USA Approval Date: 2021. 12.14
Company
Generic Name: Upadacitinib
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 10
RTM
RTM Web-Site

USA. A. PsA>Treat>JAK Inh. Tab.'s products
This section has no products